A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations (Balise)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01897480
Recruitment Status : Active, not recruiting
First Posted : July 12, 2013
Last Update Posted : December 4, 2018
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 14, 2016
  Estimated Study Completion Date : July 8, 2020
  Certification/Extension First Submitted : August 13, 2016